Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256403971> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4256403971 abstract "Polymorphism is the ability of a compound in the solid state to exist in different crystalline forms. Molecules, having the same chemical composition, exhibit different spatial arrangements and/or exist in different configurations and conformations. In pseudopolymorphs (solvates) molecules of solvents are incorporated into the crystal lattice. Contrary to the crystalline forms of polymorphs, amorphous forms are characterized by the lack of long-range molecule arrangements. The spatial arrangement of molecules in an active substance determines its physical properties and influences the bioavailability and stability of a drug product. The most frequent phase transitions that can be present in an active substance include: polymorphic transition, hydration, dehydration, amorphisation and crystallization. The knowledge about the phase transitions which can arise during the active substance manufacturing, formulation process and stability studies is very important. Phase transitions may lead to the formation of an undesirable phase of the active substance with different properties than its desirable form. Studies of phase transitions in an active substance contained in a solid dosage form are very complicated, because there are many additional factors to consider, including a small concentration of the active substance, the presence of crystalline and amorphous placebo constituents, as well as the interactions between the active substance and the excipients. There are a number of methods used to characterize crystalline and amorphous forms of the active substance. A definitive evidence of polymorphism or pseudopolymorphism is the demonstration of a nonequivalent structure by single crystal X-ray diffraction. X-ray powder diffraction (XRPD) and variable temperature X-ray powder diffraction (VT-XRPD) can also be used to provide an unequivocal proof of polymorphism and pseudopolymorphism. Other methods, including e.g. differential scanning calorimetry (DSC), thermogravimetric analysis (TGA) as well as Raman (RS) and infrared spectroscopes (IR), help to further characterize the crystalline and amorphous forms. In this presentation, a few examples of phase transition studies in the active substances and solid dosage forms will be discussed: structural and physicochemical studies of olopatadine hydrochloride conformational polymorphs, phase transitions of dutasteride performed by the VT-XRPD method, erlotynib polymorphism studies performed by means of RS and the evaluation of analytical methods for the detection of phase transitions in tablets containing aripiprazole and imatinib." @default.
- W4256403971 created "2022-05-12" @default.
- W4256403971 creator A5005051037 @default.
- W4256403971 creator A5030098381 @default.
- W4256403971 creator A5046059748 @default.
- W4256403971 date "2016-03-04" @default.
- W4256403971 modified "2023-10-18" @default.
- W4256403971 title "Detection of phase transitions in the studies of active substances and solid dosage forms" @default.
- W4256403971 doi "https://doi.org/10.7287/peerj.preprints.1821" @default.
- W4256403971 hasPublicationYear "2016" @default.
- W4256403971 type Work @default.
- W4256403971 citedByCount "0" @default.
- W4256403971 crossrefType "posted-content" @default.
- W4256403971 hasAuthorship W4256403971A5005051037 @default.
- W4256403971 hasAuthorship W4256403971A5030098381 @default.
- W4256403971 hasAuthorship W4256403971A5046059748 @default.
- W4256403971 hasBestOaLocation W42564039711 @default.
- W4256403971 hasConcept C104317684 @default.
- W4256403971 hasConcept C120665830 @default.
- W4256403971 hasConcept C121332964 @default.
- W4256403971 hasConcept C135763542 @default.
- W4256403971 hasConcept C149288129 @default.
- W4256403971 hasConcept C149737253 @default.
- W4256403971 hasConcept C178790620 @default.
- W4256403971 hasConcept C185039092 @default.
- W4256403971 hasConcept C185592680 @default.
- W4256403971 hasConcept C192562407 @default.
- W4256403971 hasConcept C203036418 @default.
- W4256403971 hasConcept C207114421 @default.
- W4256403971 hasConcept C32909587 @default.
- W4256403971 hasConcept C44280652 @default.
- W4256403971 hasConcept C45904493 @default.
- W4256403971 hasConcept C55493867 @default.
- W4256403971 hasConcept C56052488 @default.
- W4256403971 hasConcept C60644358 @default.
- W4256403971 hasConcept C8010536 @default.
- W4256403971 hasConcept C86803240 @default.
- W4256403971 hasConcept C97355855 @default.
- W4256403971 hasConceptScore W4256403971C104317684 @default.
- W4256403971 hasConceptScore W4256403971C120665830 @default.
- W4256403971 hasConceptScore W4256403971C121332964 @default.
- W4256403971 hasConceptScore W4256403971C135763542 @default.
- W4256403971 hasConceptScore W4256403971C149288129 @default.
- W4256403971 hasConceptScore W4256403971C149737253 @default.
- W4256403971 hasConceptScore W4256403971C178790620 @default.
- W4256403971 hasConceptScore W4256403971C185039092 @default.
- W4256403971 hasConceptScore W4256403971C185592680 @default.
- W4256403971 hasConceptScore W4256403971C192562407 @default.
- W4256403971 hasConceptScore W4256403971C203036418 @default.
- W4256403971 hasConceptScore W4256403971C207114421 @default.
- W4256403971 hasConceptScore W4256403971C32909587 @default.
- W4256403971 hasConceptScore W4256403971C44280652 @default.
- W4256403971 hasConceptScore W4256403971C45904493 @default.
- W4256403971 hasConceptScore W4256403971C55493867 @default.
- W4256403971 hasConceptScore W4256403971C56052488 @default.
- W4256403971 hasConceptScore W4256403971C60644358 @default.
- W4256403971 hasConceptScore W4256403971C8010536 @default.
- W4256403971 hasConceptScore W4256403971C86803240 @default.
- W4256403971 hasConceptScore W4256403971C97355855 @default.
- W4256403971 hasLocation W42564039711 @default.
- W4256403971 hasOpenAccess W4256403971 @default.
- W4256403971 hasPrimaryLocation W42564039711 @default.
- W4256403971 hasRelatedWork W1362500 @default.
- W4256403971 hasRelatedWork W20177962 @default.
- W4256403971 hasRelatedWork W2632617 @default.
- W4256403971 hasRelatedWork W6659149 @default.
- W4256403971 hasRelatedWork W7209667 @default.
- W4256403971 hasRelatedWork W7293749 @default.
- W4256403971 hasRelatedWork W8439483 @default.
- W4256403971 hasRelatedWork W8580006 @default.
- W4256403971 hasRelatedWork W9086360 @default.
- W4256403971 hasRelatedWork W20997255 @default.
- W4256403971 isParatext "false" @default.
- W4256403971 isRetracted "false" @default.
- W4256403971 workType "article" @default.